Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Eyes and Ocular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00406900
What this trial is testing

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Who this might be right for
MelanomaRadiotherapyMetastatic Disease
Ludwig-Maximilians - University of Munich 560
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Not applicableUnknownNCT05260151
What this trial is testing

Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear PalsyFrontotemporal Dementia
Xuanwu Hospital, Beijing 155
Large-scale testing (Phase 3)Ended earlyNCT00110123
What this trial is testing

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Who this might be right for
Intraocular MelanomaMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Study completedNCT04024891
What this trial is testing

Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis

Who this might be right for
MydriasisDilation
Ocuphire Pharma, Inc. 32
Not applicableUnknownNCT05696912
What this trial is testing

Functional Tests to Resolve Unsolved Rare Diseases. Rares.

Who this might be right for
Intellectual DisabilityRubinstein-Taybi SyndromeCystic Fibrosis+4 more
University Hospital, Bordeaux 50
Not applicableStudy completedNCT03852485
What this trial is testing

Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate

Who this might be right for
Normal Eyes and Eyes With Ocular Pathologies
Optovue 199
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Not applicableStudy completedNCT04804566
What this trial is testing

Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients

Who this might be right for
Fabry Disease
Amicus Therapeutics 44
Large-scale testing (Phase 3)Study completedNCT03841734
What this trial is testing

Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO

Who this might be right for
Arteritis, Giant CellBlindness and Low Vision
Centre Hospitalier Universitaire de Nice 8
Testing effectiveness (Phase 2)WithdrawnNCT00621036
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more
University of Texas Southwestern Medical Center
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT00049699
What this trial is testing

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT00416923
What this trial is testing

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Not applicableEnded earlyNCT00504205
What this trial is testing

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Astex Pharmaceuticals, Inc. 30
Very early researchStudy completedNCT01959477
What this trial is testing

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+142 more
Case Comprehensive Cancer Center 33
Next Page